ABBV

AbbVie Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-20

Figures on this page computed 2026-11-08 11:59 UTC

Last close

288.24USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-02-20

  • 122.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • 16.1%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-11-03
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-11-03

    The filing itself

  • 6.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • 29.1%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-11-03

    The filing itself

  • 2.4%Dividend yield
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • computed
    • computed
    • computed
    • computed
    • Computed from the filing for 2025, filed 2026-02-20

What it sells, to whom

lens 8 of 9

Where it sells it

2
UNITED STATES46,603,000,000 USD95.2%
Non-US2,364,000,000 USD4.8%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

0 segments, 2 places and 0 named customers, each as the filer published it.

0 segments, 2 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-20

  • UNITED STATES46,603,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD

    The filing itself

  • Non-US2,364,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0001551152-26-000008
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.